Plasma Fractionation Market Size, Share, Growth, and Industry Analysis, By Type (Hospital,Retail Pharmacy,Other), By Application (Albumin,Immune Globulin,Coagulation Factor,Others), Regional Insights and Forecast to 2035

Plasma Fractionation Market Overview 

The global Plasma Fractionation Market is forecast to expand from USD 40828.23 million in 2026 to USD 43890.35 million in 2027, and is expected to reach USD 78277.46 million by 2035, growing at a CAGR of 7.5% over the forecast period.

The Plasma Fractionation Market is a critical segment of the healthcare and biopharmaceutical sector, where plasma-derived therapies are used in 65% of chronic disease cases. Global plasma collection volume has exceeded 60 million liters annually, out of which 72% is utilized in plasma fractionation processes. Immunoglobulin therapies account for 54% of applications, while albumin holds a 24% share and coagulation factors represent 18%. The aging population accounts for 16% of the global demographic, which has increased the demand for plasma-derived therapies by 38%. Hospital-based treatments utilize 67% of plasma products, while specialty clinics generate 21% of demand.

In the USA, the Plasma Fractionation Market represents 48% of global plasma collection. More than 900 plasma collection centers operate annually. Immunoglobulin usage accounts for 58% of treatments, while albumin holds 26% and coagulation factors 14%. Chronic diseases affect 42% of the population, increasing demand for plasma therapies by 39%. Hospital utilization stands at 68%, while retail pharmacy distribution has reached 19%. Plasma donation participation is limited to 2% of the population, but it contributes 61% to global supply.

Get Comprehensive Insights into the Market’s Size and Growth Trends

Download FREE Sample

Key Findings

• Key Market Driver:  Chronic disease prevalence 42%, aging population 16%, immunoglobulin demand 54%, hospital usage 67%, plasma collection growth 61%.
• Major Market Restraint: Plasma donation rate 2%, high processing cost 37%, regulatory compliance 41%, supply chain limitation 33%, infrastructure gap 28%.
• Emerging Trends: Home therapy adoption 26%, subcutaneous delivery 31%, recombinant alternatives 22%, digital monitoring 18%, automation 29%.
• Regional Leadership: North America share 48%, Europe share 27%, Asia-Pacific share 19%, USA collection 61%, China demand 11%.
• Competitive Landscape: Top 5 players share 63%, global facilities 52%, R&D investment 34%, product pipeline 29%, strategic alliances 25%.
• Market Segmentation: Hospital share 68%, retail pharmacy 19%, other 13%, immunoglobulin 54%, albumin 24%, coagulation factor 18%.
• Recent Development: New facilities 33%, automation adoption 29%, product approvals 27%, capacity expansion 36%, partnerships 22%.

Plasma Fractionation Market Latest Trends

Plasma Fractionation Market trends show that demand for immunoglobulin therapies has reached 54%, leading to a 38% increase in treatments for neurological disorders. Subcutaneous immunoglobulin therapy has been adopted by 31% of patients, reducing hospital visits by 27%. Plasma collection automation has been implemented in 29% of facilities, improving efficiency by 33%.

Due to the aging population of 16%, albumin demand maintains a 24% share. Home-based therapy adoption has reached 26%. The Asia-Pacific region holds a 19% share in plasma demand and continues to grow. Recombinant alternatives have a 22% adoption rate, but plasma-derived therapies are still used in 78% of treatments.

Plasma Fractionation Market Dynamics

DRIVER

"Increasing demand for plasma-derived therapies"

Due to the prevalence of chronic diseases in 42% of the population, demand for plasma-derived therapies has increased by 39%. Immunoglobulin therapies account for 54% of treatments. Hospital utilization stands at 67%, where plasma products are extensively used. With an aging population of 16%, albumin demand remains stable at 24%. Annual plasma collection of 60 million liters ensures a strong supply chain.

RESTRAINT

"Limited plasma donation and high processing costs"

Plasma donation participation is limited to only 2% of the population, creating supply constraints of 33%. Processing costs are 37% higher due to complex fractionation techniques. Regulatory compliance is a challenge for 41% of companies. Infrastructure gaps in 28% of regions limit production capacity.

OPPORTUNITY

"Expansion of home-based and personalized therapies"

Home therapy adoption has reached 26%, improving patient convenience by 34%. Subcutaneous therapy is used by 31% of patients. Digital monitoring systems, with an 18% adoption rate, are improving treatment efficiency. The Asia-Pacific region, with a 19% demand share, shows strong growth potential.

CHALLENGE

"Regulatory and ethical concerns"

Regulatory frameworks create a compliance burden for 41% of companies. Ethical concerns in plasma donation create public awareness issues in 23% of cases. Supply chain disruptions affect 33% of companies. Product approval timelines cause delays in 27% of cases.

Segmentation Analysis

Get Comprehensive Insights on the Market Segmentation in this Report

Download FREE Sample

Plasma Fractionation Market segmentation shows that the hospital segment dominates with a 68% share, while retail pharmacy holds 19% and others account for 13%. By application, immunoglobulin leads with a 54% share, followed by albumin at 24%, coagulation factors at 18%, and others at 4%. Hospital-based treatments generate 67% of demand.

By Type

Hospital: The hospital segment holds a 68% share, where 67% of plasma therapies are used. Immunoglobulin treatments are used in 54% of hospital applications. Advanced treatment facilities are available in 43% of hospitals.

Retail Pharmacy: The retail pharmacy segment accounts for 19%, with outpatient treatments increasing by 34%. Due to home therapy adoption of 26%, retail distribution is expanding.

Other: The others segment holds a 13% share, including specialty clinics and research institutes. Clinical trials are conducted in 21% of facilities.

By Application

Albumin: Albumin holds a 24% share, with liver diseases affecting 18% of patients. It is used in 31% of critical care treatments.

Immune Globulin: Immunoglobulin accounts for 54% of the market, with neurological disorders included in 38% of treatments. Subcutaneous therapy adoption has reached 31%.

Coagulation Factor: Coagulation factors hold an 18% share, with hemophilia cases treated in 12% of patients. Advanced therapies have a 27% adoption rate.

Others: The others segment holds a 4% share, including specialty plasma proteins. Research applications are conducted in 19% of facilities.

Regional Outlook

Get Comprehensive Insights into the Market’s Size and Growth Trends

Download FREE Sample

North America

North America holds a 48% share, with the USA contributing 61% of plasma collection. Hospital utilization stands at 68%. Immunoglobulin therapies are used in 58% of treatments. More than 900 plasma collection centers are operational.

Europe

Europe accounts for 27% of the market, with a plasma donation rate of 1.6% of the population. Sustainable healthcare systems operate at a 44% adoption rate. Immunoglobulin demand accounts for 49% of treatments.

Asia-Pacific

Asia-Pacific holds a 19% share, with China and India as major contributors. Plasma demand accounts for 19% of the global share. Healthcare infrastructure development drives 36% of growth.

Middle East & Africa

The Middle East & Africa region holds a 6% share, where healthcare access is limited to 29% of the population. Plasma imports fulfill 71% of demand. Infrastructure development supports 24% of growth.

List of Top Plasma Fractionation Companies

• Takeda
• CSL
• Grifols
• Octapharma
• Kedrion
• LFB Group
• Biotest
• BPL
• RAAS
• CBPO
• Hualan Bio
• Tiantan Bio
• Shuanglin Bio
• Boya Bio
• Yuanda Shuyang
• Weiguang Bio
• Nanyue Bio
• KM Biologics

Top Two Companies with Highest Market Share

• CSL – market share 23%, global plasma centers 300+
• Grifols – market share 20%, collection facilities 350+

Investment Analysis and Opportunities

Investment in the Plasma Fractionation Market is focused on plasma collection and processing infrastructure, with 36% of companies expanding capacity. Automation has been adopted in 29% of facilities, improving efficiency by 33%. The Asia-Pacific region, with a 19% demand share, offers strong investment opportunities. Due to home therapy adoption of 26%, retail distribution has expanded to 19%. Around 34% of companies focus their R&D investments on personalized therapies.

New Product Development

New product development shows that subcutaneous immunoglobulin therapies have reached a 31% share. Advanced coagulation factors are growing with a 27% adoption rate. Albumin-based therapies are used in 24% of applications. Automation technology has been integrated into 29% of production facilities. Digital monitoring systems, with an 18% adoption rate, are improving patient outcomes.

Five Recent Developments (2023-2025)

• New plasma collection facilities increased by 33%
• Automation adoption implemented in 29% of plants
• Product approvals increased by 27%
• Capacity expansion carried out in 36% of facilities
• Strategic partnerships established by 22% of companies

Report Coverage of Plasma Fractionation Market

The Plasma Fractionation Market Report covers global plasma collection of 60 million liters and immunoglobulin share of 54%. Market segmentation includes hospital at 68% and immunoglobulin at 54%. Regional analysis highlights North America with a 48% share. Technological advancements such as automation at 29% and subcutaneous therapy at 31% are included. The competitive landscape shows top players controlling 63% of the market.

Plasma Fractionation Market Report Coverage

REPORT COVERAGE	DETAILS
Market Size Value In	USD 40828.23 Million in 2026
Market Size Value By	USD 78277.46 Million by 2035
Growth Rate	CAGR of 7.5% from 2026-2035
Forecast Period	2026 - 2035
Base Year	2025
Historical Data Available	Yes
Regional Scope	Global
Segments Covered	By Type : Hospital Retail Pharmacy Other By Application : Albumin Immune Globulin Coagulation Factor Others
To Understand the Detailed Market Report Scope & Segmentation Download FREE Sample